Skyworks appoints Robert Schriesheim interim CFO after CFO-elect Dentinger withdraws due to medical condition

SKYWORKS SOLUTIONS, INC.

Mark Dentinger, expected to become CFO on June 2, 2025, will not commence employment due to an unforeseen medical condition.
Board member Robert Schriesheim appointed interim CFO effective May 29, 2025; company has started search for a permanent CFO.
Schriesheim receives $625K annual base salary, $1.2M RSU award vesting over two years, and travel reimbursements.
CEO Philip Brace previously served as interim principal financial officer since May 9; now Schriesheim assumes that role.
Schriesheim served on board since 2006; past CFO at Sears, Hewitt Associates, Lawson Software.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Philip G. Brace

principal financial officer and principal accounting officer (interim)

SWKS · SKYWORKS SOLUTIONS, INC.

Effective: 2025-05-29
Successor: Robert A. Schriesheim
Filed: May 29, 2025 23:59 UTC

Philip G. Brace, the Company’s Chief Executive Officer, who has served as the Company’s principal financial officer and principal accounting officer on an interim basis since May 9, 2025, ceased serving in such roles upon Mr. Schriesheim’s appointment.

Appointed (interim)

Robert A. Schriesheim

interim Chief Financial Officer

SWKS · SKYWORKS SOLUTIONS, INC.

Effective: 2025-05-29
Filed: May 29, 2025 23:59 UTC

On May 29, 2025, the Board of Directors (the “Board”) of Skyworks Solutions, Inc. (the “Company”) appointed Robert A. Schriesheim, a current member of the Board, as interim Chief Financial Officer of the Company, effective immediately.

Departed

Mark P. Dentinger

Chief Financial Officer

SWKS · SKYWORKS SOLUTIONS, INC.

Successor: Robert A. Schriesheim
Filed: May 29, 2025 23:59 UTC

decision by Mark P. Dentinger, who had been expected to join as Chief Financial Officer on June 2, 2025, to not commence employment with the Company due to an unforeseen medical condition.

Source: SEC EDGAR

accession 0000004127-25-000064

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.